Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer
暂无分享,去创建一个
F. Fang | Zhicheng Wang | Hongguang Zhao | R. Gui | Han Yuan
[1] Han Shuwen,et al. Using whole-genome sequencing (WGS) to plot colorectal cancer-related gut microbiota in a population with varied geography , 2022, Gut Pathogens.
[2] R. Palmqvist,et al. Tumour Colonisation of Parvimonas micra Is Associated with Decreased Survival in Colorectal Cancer Patients , 2022, Cancers.
[3] Kui Luo,et al. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. , 2022, Chemical Society reviews.
[4] Ruitao Cha,et al. Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments , 2022, Science advances.
[5] J. Crawford,et al. Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites , 2022, Science.
[6] Y. Hamamoto,et al. CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule , 2022, BMC Cancer.
[7] Jie Ma,et al. Predictive value of tumor-infiltrating lymphocytes detected by flow cytometry in colorectal cancer. , 2022, International immunopharmacology.
[8] Guolian Zhu,et al. Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis , 2022, BMC Gastroenterology.
[9] Jiarui Li,et al. Immunotherapies catering to the unmet medical need of cold colorectal cancer , 2022, Frontiers in Immunology.
[10] Y. Zhang,et al. Mechanism and strategies of immunotherapy resistance in colorectal cancer , 2022, Frontiers in Immunology.
[11] Lei Zhang,et al. Inhibition of UBA6 by inosine augments tumour immunogenicity and responses , 2022, Nature Communications.
[12] Jianzhuang Ren,et al. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment , 2022, Frontiers in Immunology.
[13] F. Baltazar,et al. Colon microbiota modulation by dairy-derived diet: new strategy for prevention and treatment of colorectal cancer. , 2022, Food & function.
[14] L. D. Di Stasi,et al. Gut microbiota, inflammatory bowel disease and colorectal cancer , 2022, World journal of gastroenterology.
[15] Helen Y Wang,et al. Interaction between microbiota and immunity and its implication in colorectal cancer , 2022, Frontiers in Immunology.
[16] S. Wong,et al. Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients , 2022, Oncogene.
[17] Xuan Yi,et al. Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy. , 2022, ACS nano.
[18] Fenghua Wang,et al. Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study , 2022, Journal of Cancer.
[19] Chunyan Wu,et al. Integrated analysis of colorectal cancer reveals cross-cohort gut microbial signatures and associated serum metabolites. , 2022, Gastroenterology.
[20] C. Guda,et al. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer , 2022, Microbiology spectrum.
[21] Harpreet Kaur,et al. Probiotics and gut microbiota: mechanistic insights into gut immune homeostasis through TLR pathway regulation. , 2022, Food & function.
[22] Qing Li,et al. Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis , 2022, Frontiers in Physiology.
[23] Kuerbannaimu Kaheman,et al. Lactobacillus acidophilus and HKL Suspension Alleviates Ulcerative Colitis in Rats by Regulating Gut Microbiota, Suppressing TLR9, and Promoting Metabolism , 2022, Frontiers in Pharmacology.
[24] C. Cheze-le Rest,et al. FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer. , 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[25] Hongzhong Li,et al. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies , 2022, Journal of Hematology & Oncology.
[26] Teng Liu,et al. 131I-αPD-L1 immobilized by bacterial cellulose for enhanced radio-immunotherapy of cancer. , 2022, Journal of controlled release : official journal of the Controlled Release Society.
[27] Hui Li,et al. Gut microbiota modulation: a tool for the management of colorectal cancer , 2022, Journal of Translational Medicine.
[28] Helen Y Wang,et al. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity , 2022, Frontiers in Immunology.
[29] V. Notario,et al. The Interplay among Radiation Therapy, Antibiotics and the Microbiota: Impact on Cancer Treatment Outcomes , 2022, Antibiotics.
[30] S. Wong,et al. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers , 2022, Microbiome.
[31] C. Heeschen,et al. Multi-kingdom microbiota analyses identify bacterial–fungal interactions and biomarkers of colorectal cancer across cohorts , 2022, Nature Microbiology.
[32] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[33] Jared C Malke,et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response , 2021, Science.
[34] A. Korman,et al. The foundations of immune checkpoint blockade and the ipilimumab approval decennial , 2021, Nature Reviews Drug Discovery.
[35] Jun Yu,et al. Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis , 2021, Gut.
[36] Bangmao Wang,et al. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation? , 2021, Cancer letters.
[37] F. Ris,et al. Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer , 2021, BMC Cancer.
[38] M. Kudo,et al. Intestinal Microbiota and Gene Expression Reveal Similarity and Dissimilarity Between Immune-Mediated Colitis and Ulcerative Colitis , 2021, Frontiers in Oncology.
[39] Lingmao Tang,et al. Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model , 2021, Frontiers in Cellular and Infection Microbiology.
[40] R. Rodrigues,et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment , 2021, Cell.
[41] Yan Ma,et al. The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review , 2021, Radiation oncology.
[42] A. Awasthi,et al. High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity , 2021, Science advances.
[43] R. Soares,et al. The Effects of Ionizing Radiation on Gut Microbiota, a Systematic Review , 2021, Nutrients.
[44] Juliel Espinosa,et al. Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy , 2021, Science.
[45] Jie Hong,et al. Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosomes-packaged miR-149-3p. , 2021, Gastroenterology.
[46] Mohamed Mysara,et al. Irradiation at ultra-high (FLASH) dose rates reduces acute normal tissue toxicity in the mouse gastrointestinal system. , 2021, International journal of radiation oncology, biology, physics.
[47] Emily Y. Ko,et al. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. , 2021, Cancer cell.
[48] Ying-bin Liu,et al. Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression , 2021, Cell reports. Medicine.
[49] T. Gress,et al. Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer , 2021, Nature Communications.
[50] J. Zhang,et al. A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics , 2021, Clinical and Translational Oncology.
[51] B. Saeedi,et al. Lactobacillus rhamnosus GG Orchestrates an Antitumor Immune Response , 2021, Cellular and molecular gastroenterology and hepatology.
[52] H. Geinitz,et al. Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial. , 2021 .
[53] Zhide Guo,et al. Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer , 2021 .
[54] P. Rosenstiel,et al. Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model , 2021, Cancers.
[55] S. Yooseph,et al. Bacterial community structure alterations within the colorectal cancer gut microbiome , 2021, BMC microbiology.
[56] R. Weichselbaum,et al. Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade , 2021, Gut.
[57] A. Jazaeri,et al. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers , 2021, PloS one.
[58] Ricky A. Sharma,et al. FLASH Proton Pencil Beam Scanning Irradiation Minimizes Radiation-Induced Leg Contracture and Skin Toxicity in Mice , 2021, Cancers.
[59] Mia Yang Ang,et al. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer , 2021, Scientific Reports.
[60] J. Gilbert,et al. Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation , 2021, The Journal of experimental medicine.
[61] J. Yue,et al. Radiotherapy and the gut microbiome: facts and fiction , 2021, Radiation oncology.
[62] P. Gourraud,et al. The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer , 2021, Cancers.
[63] N. Ajami,et al. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation , 2020, Communications Biology.
[64] N. Ajami,et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients , 2020, Science.
[65] Lijun Shen,et al. The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study , 2020, Frontiers in Cellular and Infection Microbiology.
[66] I. Weissman,et al. Effects of ultra-high dose rate FLASH irradiation on the tumor microenvironment in Lewis lung carcinoma: role of myosin light chain. , 2020, International journal of radiation oncology, biology, physics.
[67] M. Hitt,et al. The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer , 2020, International journal of molecular sciences.
[68] J. Shia. The diversity of tumours with microsatellite instability: molecular mechanisms and impact upon microsatellite instability testing and mismatch repair protein immunohistochemistry , 2020, Histopathology.
[69] D. McSkimming,et al. Gut Microbiota and Immune System Interactions , 2020, Microorganisms.
[70] D. Tamandl,et al. P08.04 Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): a prospective randomized, open-label, multicenter, phase II clinical trial , 2020 .
[71] Xinrui Zhao,et al. Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade , 2020, Cancers.
[72] Xingxiang He,et al. Multi-donor multi-course faecal microbiota transplantation relieves the symptoms of chronic hemorrhagic radiation proctitis , 2020, Medicine.
[73] Jun Yu,et al. Streptococcus thermophilus inhibits colorectal tumorigenesis through secreting β-galactosidase. , 2020, Gastroenterology.
[74] R. Weichselbaum,et al. Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy. , 2020, International journal of radiation oncology, biology, physics.
[75] David T. W. Tzeng,et al. The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer , 2020, Cancer Immunology Research.
[76] Kai Yang,et al. Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer , 2020, Science Advances.
[77] K. Sun,et al. Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors , 2020, Frontiers in Cell and Developmental Biology.
[78] Zhenwei Yang,et al. The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis , 2020, International Journal of Colorectal Disease.
[79] Junjie Wang,et al. Stereotactic Ablative Radiotherapy for Colorectal Cancer Liver Metastasis. , 2020, Seminars in cancer biology.
[80] S. Górska,et al. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review , 2020, Nutrients.
[81] M. Ashrafizadeh,et al. Abscopal effect in radioimmunotherapy. , 2020, International immunopharmacology.
[82] Shasha Liu,et al. Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients , 2020, Journal of Hematology & Oncology.
[83] Lijin Zhang,et al. Radiotherapy Induces Intestinal Barrier Dysfunction by Inhibiting Autophagy , 2020, ACS omega.
[84] T. Vanden Berghe,et al. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer , 2020, Nature Medicine.
[85] Saijun Fan,et al. Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein , 2020, Microbiome.
[86] N. Oleinick,et al. Ultra-High Dose Rate Effect on Circulating Immune Cells: A Potential Mechanism for FLASH Effect? , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[87] Koichi Inoue,et al. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors , 2020, JAMA network open.
[88] E. Choi,et al. The emerging role of myeloid-derived suppressor cells in radiotherapy , 2020, Radiation oncology journal.
[89] A. Rogala,et al. Strategies to Dissect Host-Microbial Immune Interactions That Determine Mucosal Homeostasis vs. Intestinal Inflammation in Gnotobiotic Mice , 2020, Frontiers in Immunology.
[90] Bota Cui,et al. Fecal microbiota transplantation: A promising treatment for radiation enteritis? , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[91] J. O’Sullivan,et al. Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers , 2020, Nature Reviews Gastroenterology & Hepatology.
[92] Guoqiang Jiang,et al. Biostimulating Gut Microbiome with Bilberry Anthocyanin Combo to Enhance Anti-PD-L1 Efficiency against Murine Colon Cancer , 2020, Microorganisms.
[93] Dongpei Li,et al. Cancer immunotherapy: Pros, cons and beyond. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[94] P. Rosenstiel,et al. Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-producing Escherichia coli in ApcMin/+ Mice. , 2020, Gastroenterology.
[95] F. Bushman,et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. , 2019, The Journal of clinical investigation.
[96] M. Delorenzi,et al. Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ , 2019, EMBO molecular medicine.
[97] Jingyan Xie,et al. Lysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer model , 2019, Scientific Reports.
[98] Yu Liu,et al. Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells , 2019, Front. Microbiol..
[99] J. Bourhis,et al. Treatment of a first patient with FLASH-radiotherapy. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[100] S. Mani,et al. Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System , 2019, Microorganisms.
[101] L. Zitvogel,et al. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[102] Koichi Ito,et al. DETERMINATION OF GUT BACTERIAL METABOLITES IN RADIATION EXPOSED MICE. , 2019, Radiation protection dosimetry.
[103] Jeong-Seok Nam,et al. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance , 2019, Journal of Experimental & Clinical Cancer Research.
[104] T. Luong,et al. The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype , 2019, Front. Immunol..
[105] K. Fitzgerald,et al. DNA sensing by the cGAS–STING pathway in health and disease , 2019, Nature Reviews Genetics.
[106] Jun Yu,et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity , 2019, Nature Microbiology.
[107] G. Reid,et al. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic , 2019, Nature Reviews Gastroenterology & Hepatology.
[108] Lisong Shen,et al. Probiotics Lactobacillus reuteri Abrogates Immune Checkpoint Blockade-Associated Colitis by Inhibiting Group 3 Innate Lymphoid Cells , 2019, Front. Immunol..
[109] P. Bork,et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation , 2019, Nature Medicine.
[110] Xia Wang,et al. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy , 2019, Journal of cellular and molecular medicine.
[111] Paul Theodor Pyl,et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer , 2019, Nature Medicine.
[112] A. Giobbie-Hurder,et al. Analysis of colorectal cancer patients treated on ETCTN 10021: A multicenter randomized trial of combined PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation. , 2019, Journal of Clinical Oncology.
[113] D. Brenner,et al. Biological effects in normal cells exposed to FLASH dose rate protons. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[114] Y. Sakai,et al. The Role of Tumor-Associated Neutrophils in Colorectal Cancer , 2019, International journal of molecular sciences.
[115] C. Brennan,et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types , 2019, Nature Genetics.
[116] D. Plichta,et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity , 2019, Nature.
[117] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[118] R. Muschel,et al. Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade , 2018, EMBO molecular medicine.
[119] Leaf Huang,et al. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis , 2018, Advanced materials.
[120] B. Yaremko,et al. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[121] David M. Alvarado,et al. Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells , 2018, Gut.
[122] H. Tilg,et al. The Intestinal Microbiota in Colorectal Cancer. , 2018, Cancer cell.
[123] M. Ciorba,et al. Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis , 2018, Current opinion in supportive and palliative care.
[124] K. Kristiansen,et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers , 2018, Microbiome.
[125] Zhenwei Dai,et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers , 2018, Microbiome.
[126] Shiyu Song,et al. The role of bacteria in cancer therapy – enemies in the past, but allies at present , 2018, Infectious Agents and Cancer.
[127] Dai Fukumura,et al. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges , 2018, Nature Reviews Clinical Oncology.
[128] Laurence Zitvogel,et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors , 2018, Science.
[129] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[130] D. Pardoll,et al. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. , 2018, Cell host & microbe.
[131] A. Plastiras,et al. Waiting Time following Neoadjuvant Chemoradiotherapy for Rectal Cancer: Does It Really Matter , 2017, Gastrointestinal Tumors.
[132] G. Banna,et al. Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer , 2017, Front. Pharmacol..
[133] Y. Kashi,et al. Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction , 2017, Gut.
[134] Soumen Roy,et al. Microbiota: a key orchestrator of cancer therapy , 2017, Nature Reviews Cancer.
[135] K. Schalper,et al. Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming. , 2016, Cancer research.
[136] M. Hettich,et al. Checkpoint Antibodies but not T Cell-Recruiting Diabodies Effectively Synergize with TIL-Inducing γ-Irradiation. , 2016, Cancer research.
[137] M. Bernstein,et al. Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. , 2016, International journal of radiation oncology, biology, physics.
[138] Jason B. Williams,et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.
[139] H. Ishwaran,et al. Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.
[140] R. Weichselbaum,et al. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. , 2014, Immunity.
[141] I. Stratford,et al. Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. , 2014, Cancer research.
[142] S. Demaria,et al. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death , 2014, Oncoimmunology.
[143] R. Weichselbaum,et al. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. , 2014, The Journal of clinical investigation.
[144] C. Pichard,et al. Interaction of ω-3 polyunsaturated fatty acids with radiation therapy in two different colorectal cancer cell lines. , 2014, Clinical nutrition.
[145] S. Ferrone,et al. Abstract 632: Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing , 2014 .
[146] Zhijian J. Chen,et al. Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.
[147] Jack David,et al. Does It Really Matter , 2012 .
[148] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[149] C. Liao,et al. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment , 2010, Proceedings of the National Academy of Sciences.
[150] B. Ramakrishna,et al. Real‐time polymerase chain reaction quantification of specific butyrate‐producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer , 2008, Journal of gastroenterology and hepatology.
[151] F. Schmidt. Meta-Analysis , 2008 .
[152] D. C. Henckel,et al. Case report. , 1995, Journal.
[153] M. Diamond. Facts and fiction. , 1994, Journal of the American Dental Association.
[154] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.